Part 1 - General Enforcement Regulations

Part 2 - General Administrative Rulings and Decisions

Part 3 - Product Jurisdiction

Part 4 - Regulation of Combination Products

Part 5 - Organization

Part 6 - XXX

Part 7 - Enforcement Policy

Part 10 - Administrative Practices and Procedures

Part 11 - Electronic Records; Electronic Signatures

Part 12 - Formal Evidentiary Public Hearing

Part 13 - Public Hearing Before a Public Board of Inquiry

Part 14 - Public Hearing Before a Public Advisory Committee

Part 15 - Public Hearing Before the Commissioner

Part 16 - Regulatory Hearing Before the Food and Drug Administration

Part 17 - Civil Money Penalties Hearings

Part 19 - Standards of Conduct and Conflicts of Interest

Part 20 - Public Information

Part 21 - Protection of Privacy

Part 25 - Environmental Impact Considerations

Part 26 - Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community

Part 50 - Protection of Human Subjects

Part 54 - Financial Disclosure by Clinical Investigators

Part 56 - Institutional Review Boards

Part 58 - Good Laboratory Practice for Nonclinical Laboratory Studies

Part 60 - Patent Term Restoration

Part 70 - Color Additives

Part 71 - Color Additive Petitions

Part 73 - Listing of Color Additives Exempt from Certification

Part 74 - Listing of Color Additives Subject to Certification

Part 80 - Color Additive Certification

Part 81 - General Specifications and General Restrictions for Provisional Color Additives for Use in Foods, Drugs, and Cosmetics

Part 82 - Listing of Certified Provisionally Listed Colors and Specifications

Part 99 - Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

Parts 83--98 - [Reserved]